$4 Million Pathology and Molecular Reference Lab Based in Florida and Serving Multiple States
Pathology and Molecular Reference Lab for Sale in Florida
On NextCompany since August 28, 2026 (today)
FL area
Business overview
The CLIA-certified pathology and molecular reference lab operates from Florida. It specializes in anatomic pathology testing and molecular testing. The lab added COVID-19 testing recently. Referral sources span Georgia, Illinois, Michigan, and North Carolina. Revenue reached nearly $1.5 million in 2019 with 30 percent EBITDA margin. Projections show 2020 revenue above $4 million.
Who is a good fit for this business
- Buyers seeking CLIA-certified labs with multi-state referral networks pursue this opportunity.
- Investors interested in pathology and molecular testing with growth projections target Florida operations.
- Acquirers value inclusion of certifications, equipment, staff, and book of business.
Details
Frequently Asked Questions
The lab performs anatomic pathology testing and molecular testing. It recently added COVID-19 testing. Operations hold CLIA certification.
Revenue reached nearly $1.5 million in 2019 with adjusted EBITDA margin near 30 percent. 2020 projections exceed $4 million. 2021 expectations range from $6 million to $7 million.
Referral footprint includes Georgia, Illinois, Michigan, and North Carolina. The lab maintains a Florida base.
The sale includes certifications, equipment, staff, and book of business. All serious offers receive consideration.